Babak Baravarian, DPM
Podiatrist · Santa Monica, CANPI 1952310799
Payments from drug & device makers
What this record shows
This record is dominated by other: $802,700 of the $1,087,244 with a category attached, or 73.8%. Johnson & Johnson accounts for 77.0% of it on its own, with 33 other manufacturers making up the rest. Reporting peaked in 2022 at $836,702 and has fallen 98.7% since, to $11,162 in 2025. Among podiatrist clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 160 payments — averaging $6795.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$837K
- Ossio Inc$80K
- Crossroads Extremity Systems, LLC$80K
- Ossio LTD$75K
- Ipsen Bioscience Inc.$7K
- Micromed Inc$2K
- plus $6K from 28 others
Across 22 payments — averaging $14,884 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ipsen Innovation$246K
- Ipsen Biopharmaceuticals, Inc$71K
- Polarityte, Inc.$10K
Across 10 payments — averaging $21,763 each. An ownership or investment interest held by the physician or an immediate family member.
- Ossio LTD$218K
- Ossio Inc$0
- Crossroads Extremity Systems, LLC$0
What the payments were for
- Royalty or licence$127,04512%
- Consulting fees$145,28913%
- Speaking & faculty fees$2,0000%
- Travel & lodging$3,8980%
- Food & beverage$3,9120%
- Education$2,4000%
- Other$802,70074%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 30 | $836,946 |
| Ossio Inc | 13 | $79,942 |
| Crossroads Extremity Systems, LLC | 40 | $79,774 |
| Ossio LTD | 2 | $75,118 |
| Ipsen Bioscience Inc. | 5 | $6,802 |
| Micromed Inc | 2 | $2,400 |
| Hydrocision, Inc. | 1 | $2,000 |
| Medical Device Business Services, Inc. | 6 | $1,236 |
| Treace Medical Concepts, Inc. | 10 | $892 |
| Stryker(2 entities) | 8 | $885 |
| Integra Lifesciences Corporation | 3 | $218 |
| Alafair Biosciences, Inc. | 2 | $177 |
| Biotissue Holdings Inc. | 7 | $114 |
| Bioventus LLC | 3 | $79 |
| Zimmer Biomet | 2 | $77 |
| Ipsen Biopharmaceuticals, Inc | 2 | $75 |
| Bone Support Inc. | 1 | $47 |
| Organogenesis Inc. | 3 | $46 |
| DJO, LLC | 1 | $44 |
| Linvatec Corporation | 1 | $40 |
| AbbVie | 2 | $39 |
| Orthofix Medical, Inc. | 2 | $39 |
| Smith+Nephew | 2 | $37 |
| Mimedx Group, Inc. | 1 | $35 |
| Tactile Systems Technology Inc | 1 | $29 |
| Nevro Corp. | 1 | $24 |
| Amniox Medical, Inc. | 2 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $19 |
| Novastep Inc. | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $17 |
| Amgen | 1 | $15 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $13 |
| Arthrosurface Incorporated | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MOTOBAND$18,832
- OSSIOfiber Cannulated Trimmable Fixation Nail System 3.0 x 50mm$14,098
- OSSIOfiber Trimmable Fixation Nail System 2.4X30 mm$14,098
- OSSIOfiber Trimmable Fixation Nail System 2.4X50 mm$14,098
- OSSIOfiber Trimmable Fixation Nail System 4.0X50mm, one implant$14,098
- OSSIOfiber Trimmable Fixation Nail System 4.0x50mm, Two implants$14,098
- Medical Implant$9,494
- DYSPORT$6,802
- TenJet$2,000
- SpineJet$2,000
- AlloJet$2,000
- PROstep$712
- Lapiplasty System$695
- INTEGRA$510
- INTEGRA DERMAL REGENERATION TEMPLATE$170
- PRIMATRIX$170
- VersaWrap$114
How this compares
$1,087,244 in reported general payments places this provider in the 95th percentile of 721 podiatrist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 24 | $256 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Santa Monica
- Hoda NaeiSanta Monica$19K
- Ryan CarterSanta Monica$8K
- Shannon RushPleasanton$1.9M
- Robert KleimanCalexico$913K
- Bruce LawrenceOceanside$810K
- David ArmstrongLos Angeles$695K
- Philip WrotslavskyPoway$269K
- Travis WestermeyerEncinitas$158K
- Adrienne EstesPomona$129K
- Ronald LiebermanEncinitas$109K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.